Article info
Research letter
Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
- Correspondence to Professor John R Stradling, Oxford Centre for Respiratory Medicine and Oxford Biomedical Research Centre, Churchill Hospital Campus, Oxford University, Oxford OX3 7LJ, UK; john.stradling{at}orh.nhs.uk
Citation
Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
Publication history
- Received June 27, 2014
- Revised August 15, 2014
- Accepted August 18, 2014
- First published September 2, 2014.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions